Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: Slow infusion versus bolus

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Schelbert, Erik B ^a,b   Testa, Stephen M ^a   Meier, Christopher G ^a   Ceyrolles, William J ^a   Levenson, Joshua E ^a   Blair, Alexander J ^c   Kellman, Peter ^d   Jones, Bobby L ^a   Ludwig, Daniel R ^a   Schwartzman, David ^a,b   Shroff, Sanjeev G ^a,e   Wong, Timothy C ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e University of Pittsburgh   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOTERIDOL; CONTRAST MEDIUM; DIAGNOSTIC AGENT; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ACCURACY; ADULT; AGED; ARTICLE; BOLUS INJECTION; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG INFUSION; FEMALE; HEART MUSCLE FIBROSIS; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE PROCESSING; MALE; MEASUREMENT; MYOCARDIAL EXTRAVASCULAR EXTRACELLULAR VOLUME FRACTION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; COMPARATIVE STUDY; COMPUTER SIMULATION; FIBROSIS; HEART DISEASE; HEART MUSCLE; IMAGE QUALITY; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; MONTE CARLO METHOD; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; UNITED STATES; WORKFLOW;

ADULT; AGED; AGED, 80 AND OVER; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; FIBROSIS; HEART DISEASES; HETEROCYCLIC COMPOUNDS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MONTE CARLO METHOD; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PENNSYLVANIA; PHANTOMS, IMAGING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; WORKFLOW; YOUNG ADULT;

EID: 79958028694     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-16     Document Type: Article

References (44)

1. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Weber KT, Brilla CG, Circulation 1991 83 1849 1865 1828192
2. Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. Anderson KP, Walker R, Urie P, Ershler PR, Lux RL, Karwandee SV, J Clin Invest 1993 92 122 140 10.1172/JCI116540 8325977 (Pubitemid 23208988)
3. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Spach MS, Dolber PC, Circ Res 1986 58 356 371 3719925 (Pubitemid 16120759)
4. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC, Hauer RN, Kirkels H, Janse MJ, de Bakker JM, Circulation 2001 104 3069 3075 10.1161/hc5001.100833 11748102 (Pubitemid 34014059)
5. Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de Jonge N, Lahpor JR, J Am Coll Cardiol 1996 27 1071 1078 10.1016/0735-1097(95)00612-5 8609323 (Pubitemid 26117694)
6. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. Wu TJ, Ong JJ, Hwang C, Lee JJ, Fishbein MC, Czer L, Trento A, Blanche C, Kass RM, Mandel WJ, et al. J Am Coll Cardiol 1998 32 187 196 10.1016/S0735-1097(98)00184-3 9669269 (Pubitemid 28351061)
7. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. McLenachan JM, Dargie HJ, Am J Hypertens 1990 3 735 740 2145865 (Pubitemid 20345997)
8. Molecular basis of arrhythmias. Shah M, Akar FG, Tomaselli GF, Circulation 2005 112 2517 2529 10.1161/CIRCULATIONAHA.104.494476 16230503 (Pubitemid 41504503)
9. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM, Circulation 1999 100 1992 2002 10556226 (Pubitemid 29529292)
10. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. Ho CY, Lopez B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, Kwong R, Gonzalez A, Colan SD, Seidman JG, et al. N Engl J Med 2010 363 552 563 10.1056/NEJMoa1002659 20818890
11. The cellular basis of dilated cardiomyopathy in humans. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, Anversa P, J Mol Cell Cardiol 1995 27 291 305 10.1016/S0022-2828(08)80028-4 7760353
12. Late Gadolinium Enhancement Cardiac Magnetic Resonance Identifies Post Infarction Myocardial Fibrosis and the Border Zone at the Near Cellular Level in ex vivo Rat Heart. Schelbert EB, Hsu LY, Anderson SA, Mohanty BD, Karim SM, Kellman P, Aletras AH, Arai AE, Circ Cardiovasc Imaging 2010 3 743 752 10.1161/CIRCIMAGING.108.835793 20847191
13. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE, Am J Physiol Heart Circ Physiol 2008 295 1234 H1242 10.1152/ajpheart.00429.2008 18660445
14. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC, Circulation 2010 122 138 144 10.1161/CIRCULATIONAHA.109.930636 20585010
15. Quantification of Diffuse Myocardial Fibrosis and its Association with Myocardial Dysfunction in Congenital Heart Disease. Broberg CS, Chugh S, Conklin C, Sahn DJ, Jerosch-Herold M, Circ Cardiovasc Imaging 2010 3 727 734 10.1161/CIRCIMAGING.108.842096 20855860
16. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM, Circulation 2008 117 629 637 10.1161/CIRCULATIONAHA.107.723262 18212288
17. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, Judd RM, Circulation 2002 106 2322 2327 10.1161/01.CIR.0000036368. 63317.1C 12403661 (Pubitemid 35244732)
18. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Laurent S, Elst LV, Muller RN, Contrast Media Mol Imaging 2006 1 128 137 10.1002/cmmi.100 17193689
19. Quantification of T1 values by SNAPSHOT-FLASH NMR imaging. Deichmann R, Hasse A, J Magn Reson 1992 96 608 612
20. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J, J Magn Reson Imaging 2007 26 1081 1086 10.1002/jmri.21119 17896383 (Pubitemid 47548170)
21. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G, Ann Intern Med 2003 139 137 147 12859163
22. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R, Circulation 1992 86 38 46 1535573
23. Ageing of the heart. Roffe C, Br J Biomed Sci 1998 55 136 148 10198472 (Pubitemid 28356591)
24. Heart, aging, and hypertension. Varagic J, Susic D, Frohlich E, Curr Opin Cardiol 2001 16 336 341 10.1097/00001573-200111000-00004 11704702 (Pubitemid 33135221)
25. Feasibility of the single-bolus strategy for measuring the partition coefficient of Gd-DTPA in patients with myocardial infarction: independence of image delay time and maturity of scar. Thornhill RE, Prato FS, Wisenberg G, White JA, Nowell J, Sauer A, Magn Reson Med 2006 55 780 789 10.1002/mrm.20830 16508912
26. Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine. Tong CY, Prato FS, Wisenberg G, Lee TY, Carroll E, Sandler D, Wills J, Magn Reson Med 1993 30 332 336 10.1002/mrm.1910300309 8412604 (Pubitemid 23264611)
27. Quantification of myocardial perfusion with FAST sequence and Gd bolus in patients with normal cardiac function. Vallee JP, Lazeyras F, Kasuboski L, Chatelain P, Howarth N, Righetti A, Didier D, J Magn Reson Imaging 1999 9 197 203 10.1002/(SICI)1522-2586(199902)9:2<197::AID-JMRI7>3.0.CO;2-X 10077013 (Pubitemid 29115341)
28. Capillary transfer constant of Gd-DTPA in the myocardium at rest and during vasodilation assessed by MRI. Fritz-Hansen T, Rostrup E, Sondergaard L, Ring PB, Amtorp O, Larsson HB, Magn Reson Med 1998 40 922 929 10.1002/mrm.1910400619 9840838 (Pubitemid 28543845)
29. Evaluation of heart perfusion in patients with acute myocardial infarction using dynamic contrast-enhanced magnetic resonance imaging. Nielsen G, Fritz-Hansen T, Dirks CG, Jensen GB, Larsson HB, J Magn Reson Imaging 2004 20 403 410 10.1002/jmri.20142 15332247 (Pubitemid 39121938)
30. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Arheden H, Saeed M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R, Dae MW, Wendland MF, Radiology 1999 211 698 708 10352594 (Pubitemid 29249466)
31. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Flacke SJ, Fischer SE, Lorenz CH, Radiology 2001 218 703 710 11230643 (Pubitemid 32172551)
32. How we perform delayed enhancement imaging. Kim RJ, Shah DJ, Judd RM, J Cardiovasc Magn Reson 2003 5 505 514 10.1081/JCMR-120022267 12882082 (Pubitemid 36859434)
33. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Kellman P, Arai AE, McVeigh ER, Aletras AH, Magn Reson Med 2002 47 372 383 10.1002/mrm.10051 11810682 (Pubitemid 34116807)
34. Statistical methods for assessing agreement between two methods of clinical measurement. Bland JM, Altman DG, Lancet 1986 1 307 310 2868172 (Pubitemid 16134762)
35. Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia. Roberts WC, Ferrans VJ, Hum Pathol 1975 6 287 342 10.1016/S0046-8177(75)90003-9 124302
36. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P, Circulation 1994 89 151 163 8281642 (Pubitemid 24026485)
37. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. Rossi MA, J Hypertens 1998 16 1031 1041 10.1097/00004872-199816070-00018 9794745 (Pubitemid 28367959)
38. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Barkhausen J, Ruehm SG, Goyen M, Buck T, Laub G, Debatin JF, Radiology 2001 219 264 269 11274568 (Pubitemid 32234085)
39. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Cheng S, Fernandes VR, Bluemke DA, McClelland RL, Kronmal RA, Lima JA, Circ Cardiovasc Imaging 2009 2 191 198 10.1161/CIRCIMAGING.108.819938 19808592
40. Myocyte cell loss and myocyte hypertrophy in the aging rat heart. Anversa P, Hiler B, Ricci R, Guideri G, Olivetti G, J Am Coll Cardiol 1986 8 1441 1448 10.1016/S0735-1097(86)80321-7 2946746 (Pubitemid 17208926)
41. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Capasso JM, Circ Res 1990 67 871 885 2145091 (Pubitemid 20315019)
42. T(1) quantification with inversion recovery TrueFISP. Scheffler K, Hennig J, Magn Reson Med 2001 45 720 723 10.1002/mrm.1097 11284003 (Pubitemid 32260097)
43. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. Piechnik SK, Ferreira VM, Dall'armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD, J Cardiovasc Magn Reson 2010 12 69 10.1186/1532-429X-12-69 21092095
44. Cardiovascular magnetic resonance in cardiac amyloidosis. Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, Poole-Wilson PA, Hawkins PN, Pennell DJ, Circulation 2005 111 186 193 10.1161/01.CIR. 0000152819.97857.9D 15630027 (Pubitemid 40139730)